NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

ASX:NSB Revenue

In the fiscal year ending June 30, 2026, NeuroScientific Biopharmaceuticals had annual revenue of 402.66K AUD. NeuroScientific Biopharmaceuticals had revenue of 84.75K in the half year ending June 30, 2026, a decrease of -96.17%.

• Revenue: 402.66K
• Revenue Growth: n/a
• P/S Ratio: 62.91
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 25.33M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	402.66K	-	-
Jun 30, 2025	-	-	-
Jun 30, 2024	2.21M	-2.74M	-55.34%
Jun 30, 2023	4.95M	-	-
Jun 30, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error